- ►diabetesjournals.org JR Goss, WF Goins, D Lacomis, M Mata, JC … - Diabetes, 2002 - Am Diabetes Assoc Peripheral neuropathy is a common and debilitating complication of diabetes. In
animal models, neurotrophic factors can prevent progression of the neuropathy,
but adverse effects prevent systemic administration in adequate doses to ... Cited by 78 - Related articles - BL Direct - All 6 versions
M Chattopadhyay, J Goss, D Lacomis, WC … - European Journal of Neuroscience, 2003 - interscience.wiley.com The distinct distribution of trkA receptors on small neurons and trkC receptors
on large neurons in the dorsal root ganglion correlates with the dependence of
these two classes of neurons on nerve growth factor and neurotrophin-3, ... Cited by 27 - Related articles - BL Direct - All 5 versions
M Chattopadhyay, D Wolfe, S Huang, J Goss, … - Annals of neurology, 2002 - interscience.wiley.com Neurotrophic factors have been demonstrated to prevent the development of
peripheral neuropathy in animal models, but the therapeutic use of these factors
in human disease has been limited by the short serum half-life and ... Cited by 49 - Related articles - BL Direct - All 5 versions
PF Pradat, P Kennel, S Naimi-Sadaoui, F … - Human gene therapy, 2001 - liebertonline.com Page 1. HUMAN GENE THERAPY 12:2237–2249 (December 10, 2001) Mary Ann Liebert,
Inc. Continuous Delivery of Neurotrophin 3 by Gene Therapy ... Cited by 33 - Related articles - BL Direct - All 4 versions
- ►oxfordjournals.org M Chattopadhyay, J Goss, D Wolfe, WC Goins, … - Brain, 2004 - Oxford Univ Press Attempts to develop clinical treatments for neuropathy using neurotrophins have
not been successful. We tested whether neurotrophin gene delivery to dorsal root
ganglia (DRGs) using non-replicating herpes simplex virus (HSV)-based ... Cited by 30 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org N Kato, K Nemoto, K Nakanishi, R Morishita, … - Diabetes, 2005 - Am Diabetes Assoc Peripheral neuropathy is common and ultimately accounts for significant
morbidity in diabetes. Recently, several neurotrophic factors have been used to
prevent progression of diabetic neuropathy. In this study, we gave repeated ... Cited by 17 - Related articles - All 5 versions
S Hao, M Mata, W Goins, JC Glorioso, DJ Fink - Pain, 2003 - Elsevier We examined the pharmacologic characteristics of herpes simplex virus (HSV)
vector-mediated expression of proenkephalin in the dorsal root ganglion in a
rodent model of neuropathic pain. We found that: (i) vector-mediated ... Cited by 76 - Related articles - All 8 versions
- ►nih.gov P Schratzberger, DH Walter, K Rittig, FH … - Journal of Clinical Investigation, 2001 - Am Soc Clin Investig The pathogenetic basis for diabetic neuropathy has been enigmatic. Using two
different animal models of diabetes, we have investigated the hypothesis that
experimental diabetic neuropathy results from destruction of the vasa ... Cited by 173 - Related articles - BL Direct - All 8 versions
JR Goss, CF Harley, M Mata, ME O'Malley, WF … - Annals of neurology, 2002 - interscience.wiley.com We examined whether a herpes simplex virus vector that expresses human
proenkephalin could be used to attenuate nociception in a model of bone cancer
pain in mice. Osteolytic sarcoma cells were implanted into the medullary ... Cited by 56 - Related articles - BL Direct - All 3 versions
- ►diabetesjournals.org K Sasaki, MB Chancellor, WF Goins, MW … - Diabetes, 2004 - Am Diabetes Assoc Diabetic cystopathy is one of the common complications of diabetes and current
therapy is limited. In the present study, the effects of gene therapy, using
replication-defective herpes simplex virus type 1 (HSV-1) vectors to ... Cited by 37 - Related articles - BL Direct - All 5 versions
